{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:12:29Z","timestamp":1790374349774,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T00:00:00Z","timestamp":1311120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We have previously reported presentation serum selenium level to be predictive of outcome in diffuse large B\u2013cell lymphoma. This has now been studied in a further 430 patients, 163 with acute myeloid leukaemia (AML), 156 with Hodgkin Lymphoma (HL), and 111 with Follicular Lymphoma (FL). Serum selenium was below the UK normal reference range in 45% of patients, and correlated with serum albumin (<jats:italic>r<\/jats:italic>\u2003=\u20030\u00b724\u20130\u00b746, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001\u20130\u00b7003) in all tumour types. Independent predictors of presentation selenium were; French\u2010American\u2010British subtype and albumin (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001 for both) in AML, haemoglobin (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7002) and B\u2010symptoms (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b701) in HL, and albumin (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001) in FL. In AML and HL, response to first line therapy was lower in patients with low serum selenium, but selenium was no longer predictive of response when other variables were entered into a multivariate model. Low selenium was also associated with a worse overall survival in FL [Hazard Ratio (HR) 2\u00b73, 95% confidence interval (CI) 1\u00b74, 4\u00b70] and a trend to a worse overall survival in AML (HR 1\u00b743, 95% CI 0\u00b796, 2\u00b713) by univariate Cox regression analysis, but not by multivariate analysis. In conclusion, low serum selenium is associated with a worse outcome in patients with haematological malignancies, but is not independently predictive, suggesting that it reflects other factors.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2011.08744.x","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T09:54:49Z","timestamp":1311155689000},"page":"448-456","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies"],"prefix":"10.1111","volume":"154","author":[{"given":"Jane","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Sieniawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Kassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Montoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jude","family":"Fitzgibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ama","family":"Rohatiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Joel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2004.08.025"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000251124.83436.0E"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-009-8401-2"},{"key":"e_1_2_5_5_1","first-page":"505","article-title":"Serum selenium concentrations in patients with newly diagnosed lymphoid malignancies","volume":"80","author":"Avanzini P","year":"1995","journal-title":"Haematologica"},{"issue":"7","key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0773.1986.tb02760.x","article-title":"Serum trace elements during chemotherapy for acute myelogenous leukemia","volume":"59","author":"Beguin Y","year":"1986","journal-title":"Acta Pharmacologica et Toxicologica (Copenh)"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19871015)60:8<1842::AID-CNCR2820600828>3.0.CO;2-W"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/10.11.2089"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03563.x"},{"key":"e_1_2_5_10_1","first-page":"1832","article-title":"Allogeneic bone marrow transplantation for low\u2010grade lymphoma","volume":"92","author":"van Besien K","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114419"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0268"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603292"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540240035027"},{"key":"e_1_2_5_15_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2340\/00015555749394","article-title":"Serum selenium in melanoma and epidermotropic cutaneous T\u2010cell lymphoma","volume":"74","author":"Deffuant C","year":"1994","journal-title":"Acta Dermato Venereologica"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1039\/a608027h"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2003.04167.x"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-5107(01)00075-6"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199809000-00021"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2007.11.003"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02785304"},{"key":"e_1_2_5_22_1","first-page":"2882","article-title":"In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention","volume":"60","author":"Ip C","year":"2000","journal-title":"Cancer Research"},{"key":"e_1_2_5_23_1","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"Jaffe ES","year":"2001"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.1.140"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0519"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.145"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl004"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.864"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(01)00744-6"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-8166com"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0262"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00000665"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3180f61b3a"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-119370"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2011.08744.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.08744.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T23:27:00Z","timestamp":1697412420000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2011.08744.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1111\/j.1365-2141.2011.08744.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08744.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]},"assertion":[{"value":"2011-07-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}